Class-sparing regimens for initial treatment of HIV-1 infection.

By S. Riddler, R. Haubrich, A. DiRienzo, Lynne Peeples, W. Powderly, K. Klingman, K. Garren, T. Luke George, J. Rooney, Barbara Brizz and 5 more. New England Journal of Medicine, 2008

711 citations recorded by the source corpus.

Subfields: Emergency Medicine, Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/19ccd39a42ae54346915f73dac6677abb18a4413

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Worm
2. R. Weber
3. C. Sabin
4. P. Reiss
5. N. Friis‐Møller
6. J. Lundgren
7. W. El-Sadr
8. F. Dabis

Citations in the corpus

• Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. (2010, background): “Although efavirenz has been reported to cause elevated triglyceride levels [13, 14, 39], these increases do not appear to translate into an increased risk of clinical CVD.”